BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21217204)

  • 1. Viral disruption of promyelocytic leukemia (PML) nuclear bodies by hijacking host PML regulators.
    Frappier L
    Virulence; 2011; 2(1):58-62. PubMed ID: 21217204
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus nuclear antigen 1 Hijacks the host kinase CK2 to disrupt PML nuclear bodies.
    Sivachandran N; Cao JY; Frappier L
    J Virol; 2010 Nov; 84(21):11113-23. PubMed ID: 20719947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies.
    Sivachandran N; Sarkari F; Frappier L
    PLoS Pathog; 2008 Oct; 4(10):e1000170. PubMed ID: 18833293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein - Barr virus Latent Membrane Protein 1 suppresses reporter activity through modulation of promyelocytic leukemia protein-nuclear bodies.
    Sides MD; Block GJ; Chadwick RW; Shan B; Flemington EK; Lasky JA
    Virol J; 2011 Oct; 8():461. PubMed ID: 21975125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The herpesvirus associated ubiquitin specific protease, USP7, is a negative regulator of PML proteins and PML nuclear bodies.
    Sarkari F; Wang X; Nguyen T; Frappier L
    PLoS One; 2011 Jan; 6(1):e16598. PubMed ID: 21305000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Adenovirus DNA Replication Factor, but Not Incoming Genome Complexes, Targets PML Nuclear Bodies.
    Komatsu T; Nagata K; Wodrich H
    J Virol; 2016 Feb; 90(3):1657-67. PubMed ID: 26608315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection.
    Sivachandran N; Wang X; Frappier L
    J Virol; 2012 Jun; 86(11):6146-58. PubMed ID: 22491455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of nuclear bodies in apoptosis signalling.
    Krieghoff-Henning E; Hofmann TG
    Biochim Biophys Acta; 2008 Nov; 1783(11):2185-94. PubMed ID: 18680765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly of Epstein-Barr Virus Capsid in Promyelocytic Leukemia Nuclear Bodies.
    Wang WH; Kuo CW; Chang LK; Hung CC; Chang TH; Liu ST
    J Virol; 2015 Sep; 89(17):8922-31. PubMed ID: 26085145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional reorganization of promyelocytic leukemia nuclear bodies during BK virus infection.
    Jiang M; Entezami P; Gamez M; Stamminger T; Imperiale MJ
    mBio; 2011; 2(1):e00281-10. PubMed ID: 21304169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The deubiquitinylation and localization of PTEN are regulated by a HAUSP-PML network.
    Song MS; Salmena L; Carracedo A; Egia A; Lo-Coco F; Teruya-Feldstein J; Pandolfi PP
    Nature; 2008 Oct; 455(7214):813-7. PubMed ID: 18716620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Swine Promyelocytic Leukemia Isoform II Inhibits Pseudorabies Virus Infection by Suppressing Viral Gene Transcription in Promyelocytic Leukemia Nuclear Bodies.
    Yu C; Xu A; Lang Y; Qin C; Wang M; Yuan X; Sun S; Feng W; Gao C; Chen J; Zhang R; Tang J
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.
    Reichelt M; Wang L; Sommer M; Perrino J; Nour AM; Sen N; Baiker A; Zerboni L; Arvin AM
    PLoS Pathog; 2011 Feb; 7(2):e1001266. PubMed ID: 21304940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication.
    Sarkari F; Sanchez-Alcaraz T; Wang S; Holowaty MN; Sheng Y; Frappier L
    PLoS Pathog; 2009 Oct; 5(10):e1000624. PubMed ID: 19834552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two-step colocalization of MORC3 with PML nuclear bodies.
    Mimura Y; Takahashi K; Kawata K; Akazawa T; Inoue N
    J Cell Sci; 2010 Jun; 123(Pt 12):2014-24. PubMed ID: 20501696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The alphaherpesvirus serine/threonine kinase us3 disrupts promyelocytic leukemia protein nuclear bodies.
    Jung M; Finnen RL; Neron CE; Banfield BW
    J Virol; 2011 Jun; 85(11):5301-11. PubMed ID: 21430051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic mediated disruption of promyelocytic leukemia protein nuclear bodies induces ganciclovir susceptibility in Epstein-Barr positive epithelial cells.
    Sides MD; Block GJ; Shan B; Esteves KC; Lin Z; Flemington EK; Lasky JA
    Virology; 2011 Jul; 416(1-2):86-97. PubMed ID: 21605886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of RNF168 as a PML nuclear body regulator.
    Shire K; Wong AI; Tatham MH; Anderson OF; Ripsman D; Gulstene S; Moffat J; Hay RT; Frappier L
    J Cell Sci; 2016 Feb; 129(3):580-91. PubMed ID: 26675234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting promyelocytic leukemia protein: a means to regulating PML nuclear bodies.
    Reineke EL; Kao HY
    Int J Biol Sci; 2009 May; 5(4):366-76. PubMed ID: 19471587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.